About Seaport Therapeutics
Seaport Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2024 in Delaware. It has reported $225,899,940 raised in one offering on Form D since October 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 18, 2024 | Oct 31, 2024 | $225,899,940of $225.9M target | 33 | $6.8M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Seaport Therapeutics's Form D filed Oct 31, 2024.
JH
MC
Michael Chen
Executive officer
LG
Lana Gladstein
General Counsel
DZ
Daphne Zohar
Executive officer and director
AL
Antony Loebel
Executive officer
DW
David Wheadon
Director
EG
Eric Green
Executive officer
RN
Robert Nelsen
Director
SP
Steven Paul
Director
BC
Bharatt Chowrira
Director
DT
EE
Eric Elenko
Director
JP
Jason Pitts
Director